xerostomy treatment medication for menopause is one of the most popular treatments for menopausal symptoms, with the Italians having a huge number of options.
The country has been hailed as one of Europe’s best places to get treatment for menstrual disorders, and for good reason.
The Italian Health Insurance Agency (IHA) is currently testing a new medication called mi medical treatment medications (MiMT) which will treat menopausal depression.
In a press release, the agency said that the MiMT medication is being tested in the country to see if it can help menopausal patients in their daily lives.
MiMT is an implantable device that connects to a patient’s body through a series of channels and is implanted under the skin.
The treatment is administered in three stages, with a total of 15 treatment sessions.
The first stage is for people with a temperature of over 30C, which is the minimum recommended by the World Health Organization.
The second stage involves men with a moderate to severe temperature of 30C or above, which includes those suffering from chronic illnesses such as cancer and diabetes.
The third stage is recommended for those suffering symptoms of the condition, such as headaches, irritability, insomnia, nausea and weight loss.
MiPT is expected to be fully operational by 2018.IHA’s tests have already confirmed that the device works on the average of 75 percent of patients.
This compares with the results of more than 300,000 people who took part in trials of the device in Italy last year.
The new medication is said to be less expensive than standard treatments, but the health insurer is also looking to test the device on women who are more likely to need treatment for more serious conditions such as diabetes, heart disease and hypertension.